High expression of AGR2 in lung cancer is predictive of poor survival

Autor: Alavi, M, Mah, V, Maresh, EL, Bagryanova, L, Horvath, S, Chia, D, Goodglick, L, Liu, AY

Publikováno v: Alavi, M; Mah, V; Maresh, EL; Bagryanova, L; Horvath, S; Chia, D; et al.(2015). High expression of AGR2 in lung cancer is predictive of poor survival. BMC Cancer. doi: 10.1186/s12885-015-1658-2. UCLA: Retrieved from: http://www.escholarship.org/uc/item/3mj828b6

© 2015 Alavi et al. Background: Anterior gradient 2 (AGR2) is a protein disulfide isomerase-like protein widely expressed in many normal tissues as well as cancers. In our study, non-neoplastic bronchial epithelial cells as well as non-small cell lu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::5064d1318b584668155844d737083e1b
http://www.escholarship.org/uc/item/3mj828b6

Neurophysiological correlates of cognitive control and approach motivation abnormalities in adolescent bipolar disorders.

Autor: Maresh EL; Minneapolis VA Health Care System, Psychology Services #116B, One Veterans Drive, Minneapolis, MN, 55417, USA.; Department of Psychology, University of Arizona, Tucson, AZ, USA., Stim JJ; Minneapolis VA Health Care System, Psychology Services #116B, One Veterans Drive, Minneapolis, MN, 55417, USA.; Department of Psychology, University of Minnesota-Twin Cities, Minneapolis, MN, USA., Van Voorhis AC; Minneapolis VA Health Care System, Psychology Services #116B, One Veterans Drive, Minneapolis, MN, 55417, USA., Kang SS; Minneapolis VA Health Care System, Psychology Services #116B, One Veterans Drive, Minneapolis, MN, 55417, USA.; Department of Psychiatry, University of Missouri-Kansas City, Kansas City, MI, USA., Luciana M; Department of Psychology, University of Minnesota-Twin Cities, Minneapolis, MN, USA., Sponheim SR; Minneapolis VA Health Care System, Psychology Services #116B, One Veterans Drive, Minneapolis, MN, 55417, USA.; Department of Psychiatry, University of Minnesota-Twin Cities, Minneapolis, MN, USA., Urošević S; Minneapolis VA Health Care System, Psychology Services #116B, One Veterans Drive, Minneapolis, MN, 55417, USA. snezana.urosevic@gmail.com.; Department of Psychiatry, University of Minnesota-Twin Cities, Minneapolis, MN, USA. snezana.urosevic@gmail.com.

Publikováno v: Cognitive, affective & behavioral neuroscience [Cogn Affect Behav Neurosci] 2019 Jun; Vol. 19 (3), pp. 677-691.

MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4.

Autor: Hong CS; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA., Graham NA; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Crump Institute for Molecular Imaging, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA., Gu W; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA., Espindola Camacho C; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA., Mah V; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA., Maresh EL; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA., Alavi M; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA., Bagryanova L; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA., Krotee PAL; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA., Gardner BK; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA., Behbahan IS; Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA., Horvath S; Department of Biostatistics, Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA., Chia D; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA., Mellinghoff IK; Department of Neurology, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065 USA; Department of Pharmacology, Weill-Cornell Medical College, New York, NY 10065, USA., Hurvitz SA; Division of Hematology/Oncology, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA., Dubinett SM; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA., Critchlow SE; Oncology iMed, AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK., Kurdistani SK; Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, Los Angeles, CA 90095, USA., Goodglick L; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA., Braas D; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; UCLA Metabolomics Center, University of California, Los Angeles, Los Angeles, CA 90095, USA., Graeber TG; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Crump Institute for Molecular Imaging, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; UCLA Metabolomics Center, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA., Christofk HR; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; UCLA Metabolomics Center, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, Los Angeles, CA 90095, USA. Electronic address: hchristofk@mednet.ucla.edu.

Publikováno v: Cell reports [Cell Rep] 2016 Feb 23; Vol. 14 (7), pp. 1590-1601. Date of Electronic Publication: 2016 Feb 11.

Ribonucleotide reductase subunit M2 predicts survival in subgroups of patients with non-small cell lung carcinoma: effects of gender and smoking status.

Autor: Mah V; Department of Pathology and Laboratory Medicine, UCLA, Los Angeles, California, 90095, United States of America., Alavi M; Department of Pathology and Laboratory Medicine, UCLA, Los Angeles, California, 90095, United States of America., Márquez-Garbán DC; Department of Medicine, Division of Hematology-Oncology, UCLA, Los Angeles, California, 90095, United States of America; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California, 90095, United States of America., Maresh EL; Department of Pathology and Laboratory Medicine, UCLA, Los Angeles, California, 90095, United States of America., Kim SR; Department of Pathology and Laboratory Medicine, UCLA, Los Angeles, California, 90095, United States of America., Horvath S; Department of Biostatistics, UCLA, Los Angeles, California, 90095, United States of America; Department of Human Genetics, UCLA, Los Angeles, California, 90095, United States of America; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California, 90095, United States of America., Bagryanova L; Department of Pathology and Laboratory Medicine, UCLA, Los Angeles, California, 90095, United States of America., Huerta-Yepez S; Unidad de Investigación en Enfermedades Oncológicas, Hospital Infantil de México, Federico Gómez, SSa, México., Chia D; Department of Pathology and Laboratory Medicine, UCLA, Los Angeles, California, 90095, United States of America; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California, 90095, United States of America., Pietras R; Department of Medicine, Division of Hematology-Oncology, UCLA, Los Angeles, California, 90095, United States of America; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California, 90095, United States of America., Goodglick L; Department of Pathology and Laboratory Medicine, UCLA, Los Angeles, California, 90095, United States of America; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California, 90095, United States of America.

Publikováno v: PloS one [PLoS One] 2015 May 22; Vol. 10 (5), pp. e0127600. Date of Electronic Publication: 2015 May 22 (Print Publication: 2015).

Increased default mode network activity in socially anxious individuals during reward processing.

Autor: Maresh EL; Department of Psychology, University of Virginia, 314 Gilmer Hall, P.O. Box 400400, Charlottesville, VA 22904, USA., Allen JP; Department of Psychology, University of Virginia, 314 Gilmer Hall, P.O. Box 400400, Charlottesville, VA 22904, USA., Coan JA; Department of Psychology, University of Virginia, 314 Gilmer Hall, P.O. Box 400400, Charlottesville, VA 22904, USA.

Publikováno v: Biology of mood & anxiety disorders [Biol Mood Anxiety Disord] 2014 Jul 23; Vol. 4, pp. 7. Date of Electronic Publication: 2014 Jul 23 (Print Publication: 2014).